CIK 0001093557
- Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330857544
- Phone
- +1 858-200-0200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −210 | $153.34 | $32K | 80,751 |
| 2019-10-07 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Other disposition | −18,377 | 48,444 | ||
| 2019-10-07 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Other acquisition | +18,377 | 18,377 | ||
| 2019-10-01 | ALTMAN STEVEN R Director | Sale | −1,700 | $148.83 | $253K | 49,604 |
| 2019-10-01 | ALTMAN STEVEN R Director | Sale | −800 | $149.88 | $120K | 48,804 |
| 2019-10-01 | SAYER KEVIN R President, CEO and Chairman | Sale | −2,006 | $148.68 | $298K | 230,931 |
| 2019-10-01 | SAYER KEVIN R President, CEO and Chairman | Sale | −4,866 | $149.52 | $728K | 226,065 |
| 2019-10-01 | SAYER KEVIN R President, CEO and Chairman | Sale | −3,128 | $150.31 | $470K | 222,937 |
| 2019-09-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −1,497 | $154.80 | $232K | 519 |
| 2019-09-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −519 | $155.57 | $81K | 0 |
| 2019-09-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −1,000 | $155.11 | $155K | 82,815 |
| 2019-09-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −532 | $156.15 | $83K | 82,283 |
| 2019-09-18 | Balo Andrew K * | Sale | −2,386 | $151.46 | $361K | 57,916 |
| 2019-09-16 | AUGUSTINOS NICHOLAS Director | Sale | −1,208 | $145.49 | $176K | 8,062 |
| 2019-09-13 | Heller Bridgette P Director | Grant or award | +3,036 | $0.00 | $3 | 3,036 |
| 2019-09-11 | MOY JEFFREY EVP Operations | Other disposition | −4,461 | 30,408 | ||
| 2019-09-11 | MOY JEFFREY EVP Operations | Other acquisition | +4,461 | 31,819 | ||
| 2019-09-10 | Blackford Quentin S. EVP Chief Financial Officer | Sale | −1,800 | $139.29 | $251K | 78,274 |
| 2019-09-10 | Blackford Quentin S. EVP Chief Financial Officer | Sale | −2,500 | $140.47 | $351K | 75,774 |
| 2019-09-10 | Blackford Quentin S. EVP Chief Financial Officer | Sale | −3,725 | $141.62 | $528K | 72,049 |
Page 69 of 72 · 1,429 trades